BeyondSpring director granted 23,902 stock options
BeyondSpring Inc. director Matthew Kirkby received a grant of stock options covering 23,902 ordinary shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BeyondSpring Inc. director Matthew Kirkby received a grant of stock options covering 23,902 ordinary shares. The options have an exercise price of $1.64 per share and expire on April 1, 2036. All options vest on April 1, 2027, contingent on his continuous service with the company.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (right to buy) | 23,902 | $0.00 | $0.00 |
Footnotes (1)
- F1. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date.
Key Figures
Key Terms
Stock Options (right to buy) financial
2017 Omnibus Incentive Plan financial
exercise price financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BYSI director Matthew Kirkby report?
What is the exercise price of Matthew Kirkby’s BYSI stock options?
When do Matthew Kirkby’s BeyondSpring stock options vest?
When do the newly granted BYSI stock options held by Kirkby expire?
Under which plan were Matthew Kirkby’s BeyondSpring options granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.